A Study of LY3462817 in Participants With Rheumatoid Arthritis
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Eli Lilly and Company
Related studies linked through entity extraction aliases.
ABEMA Alone or in COMBO With MK-6482
- Status
- COMPLETED
- Phase
- PHASE1
Chronic Pain Master Protocol (CPMP): A Study of LY3556050 in Participants With Osteoarthritis
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Lebrikizumab (LY3650150) on Vaccine Response in Adults With Atopic Dermatitis (ADopt-VA)
- Status
- COMPLETED
- Phase
- PHASE3
Safety and Efficacy Study of Epcoritamab in Subjects With Relapsed/Refractory Chronic Lymphocytic Leukemia and Richter's Syndrome
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation.
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
A Virtual Prospective Study Exploring Activity Trackers and COVID-19 Infections
- Status
- COMPLETED
- Phase
- N/A
Improving the Approach to and Management of the Older Patient With Metastatic Gastric Cancer
- Status
- UNKNOWN
- Phase
- NA
A Study of Galcanezumab (LY2951742) in Participants 12 to 17 Years of Age With Chronic Migraine
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Single Cell Immune and Non-immune Correlates of Response to Neoadjuvant Abemaciclib
- Status
- RECRUITING
- Phase
- PHASE2
Assessing Closed-loop Insulin Delivery in Children With Type 1 Diabetes.
- Status
- TERMINATED
- Phase
- NA
A Study of LY3832479 (LY-CoV016) in Healthy Participants 1
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Mirikizumab in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Encorafenib Plus Cetuximab With or Without Chemotherapy in People With Previously Untreated Metastatic Colorectal Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Study of Mealtime Insulin LY900014 in Participants With Type 2 Diabetes Using Continuous Glucose Monitoring (PRONTO-Time in Range)
- Status
- COMPLETED
- Phase
- PHASE3
Expanded Access Program to Provide Bamlanivimab (LY3819253) for the Treatment of COVID-19
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A
ABemaciclib, ET ± paclItaxel in aGgressive HR+/HER2- MBC trIaL
- Status
- COMPLETED
- Phase
- PHASE2
Study of Oral LY3410738 in Patients With Advanced Hematologic Malignancies With IDH1 or IDH2 Mutations
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Study of Dulaglutide (LY2189265) in Chinese Participants With Type 2 Diabetes
- Status
- COMPLETED
- Phase
- PHASE3
A Study of LY3509754 in Healthy Non-Japanese and Japanese Participants
- Status
- TERMINATED
- Phase
- PHASE1